Purified anti-CD141 Thrombomodulin Antibody anti-CD141 (Thrombomodulin) - Phx-01,BioLegend,902101
This antibody is effective in immunoblotting, immunohistochemistry (IHC) and ELISA.*Predicted MW = 60 kDPositive control tissue: human placentaThis antibody reacts with an epitope within the EGF 5 domain and inhibits thrombin binding.
Host
Mouse
Reactivity
Human
Application
IHC-F -Quality testedWB, ELISA -Verified
Platform ID
BAB828915247

BioLegend
Contact
Tel: 1-858-455-9588
Fax: +49 (4131) 7023913
Email:
Specifications
Scientific Background
CD141 is a 75 kD, single chain, type I membrane glycoprotein also known as thrombomodulin, TM, THRM, THBD, and fetomodulin. CD141 is an important cofactor in the protein C anticoagulant system. After binding to its ligand thrombin, CD141 activates protein C, which degrades clotting factors Va and VIIIa, and as a consequence the amount of thrombin is reduced. CD141 is expressed on macrophages, monocytes, a subpopulation of myeloid dendritic cells, vascular endothelial cells, and keratinocytes. Besides anti-coagulation function, CD141 is also involved in embryonic and atherosclerotic plaque development. CD141 is an endothelial cell surface glycoprotein involved in the regulation of coagulation. Via a direct interaction with thrombin, thrombomodulin causes down-regulation of multiple pro-coagulation pathways in order to preserve the anticoagulant properties of the endothelial cell surface.
Category Paths
- Products>Primary Antibodies>IHC Antibodies
Please provide the required information below so that we can quickly source your products.
